• No results found

Stepping into the RING: preclinical models in the fight against hereditary breast cancer - Cover

N/A
N/A
Protected

Academic year: 2021

Share "Stepping into the RING: preclinical models in the fight against hereditary breast cancer - Cover"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Stepping into the RING: preclinical models in the fight against hereditary breast

cancer

Drost, R.M.

Publication date

2012

Link to publication

Citation for published version (APA):

Drost, R. M. (2012). Stepping into the RING: preclinical models in the fight against hereditary

breast cancer. Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis.

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.

(2)

Stepping into

the

RING

Rinske Drost

Pr

eclinical models in the figh

t against her

editar

y br

east canc

er

Rinsk

e D

rost

2012

Preclinical models

in the fight against

hereditary breast cancer

door Rinske Drost

op vrijdag 14 september 2012

om 14:00 uur

in de Agnietenkapel van de Universiteit van Amsterdam Oudezijds Voorburgwal 231 Na afloop van de verdediging

bent u van harte welkom op de receptie ter plaatse

Rinske Drost Den Brielstraat 11 3554 XD Utrecht 06-52694674 r.drost@nki.nl PArANimfeN Ute Boon 06-13308076 u.boon@nki.nl Karlijn Drost 06-50894020 karlijndrost@hotmail.com

Uitnodiging

voor het bijwonen van de openbare verdediging

van het proefschrift:

Stepping into

the

RING

Preclinical models

in the fight against

hereditary breast cancer

Referenties

GERELATEERDE DOCUMENTEN

While the physician, who sustained the needle stick injury, had a normal plasma ALAT level (upper limit of normal (ULN) 45 U/L) and his plasma was negative for antibodies to

The same interferon high dose induction schedule for 2 weeks in combination with ribavirin and amantadine (another broad spectrum anti-viral drug) was the treatment given to

We concludeerden dat relapse patiënten die niet besmet waren met het genotype 1, een zeer grote kans hadden om van het virus af te komen door slechts 24 weken behandeling, als ze na

Marcel Beid heeft er voor gezorgd dat ik, als gewone 'mensendokter', tenslotte toch ook iets van het hepatitis C-virus ben gaan snappen, door mij met engelengeduld steeds opnieuw

Bij het wikken en wegen om aan een behandeling van een chronische hepatitis C infectie te beginnen, neemt het gewicht van een leverbiopt steeds meer af en niet alleen bij genotype 2

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly

In line with metabolic control analysis of steady state fluxes and concentrations, one may define the extent to which an enzyme (or process described in. Table

Using this value for the actin filament Young’s modulus, its contribution to the elastic properties of skeletal muscle fibre of the frog is considered in rigor and relaxation..